Emerging drugs for the treatment of clostridium difficile-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Emerging drugs for the treatment of clostridium difficile

Published:2019-01-02 Issue:1 Volume:24 Page:17-28
ISSN:1472-8214
Container-title:Expert Opinion on Emerging Drugs
language:en
Short-container-title:Expert Opinion on Emerging Drugs

Author:

Cammarota Giovanni¹,Gallo Antonella²,Ianiro Gianluca³,Montalto Massimo¹

Affiliation:

1. UOC di Medicina Interna, F. Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy

2. UOC di Medicina Interna, F. Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

3. UOC di Medicina Interna e Gastroenterologia, F. Policlinico Universitario A. Gemelli IRCCS, Roma, Italy

Funder

not funded

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14728214.2019.1591371

Reference103 articles.

1. Reclassification of Clostridium difficile as Clostridioides difficile (Hall and O’Toole 1935) Prévot 1938

2. Clostridium difficile— More Difficult Than Ever

3. Clostridium difficile Infection

4. Risk Factors for Recurrence, Complications and Mortality in Clostridium difficile Infection: A Systematic Review

5. The Changing Epidemiology of Clostridium difficile Infections

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is there a role for intestinal sporobiota in the antimicrobial resistance crisis?;Microbiological Research;2024-11

2. Clostridioides difficile infection: a changing treatment paradigm;Gastroenterology Review;2024

3. Metagenomics and metabolomics approaches in the study of Candida albicans colonization of host niches: a framework for finding microbiome-based antifungal strategies;Trends in Microbiology;2023-12

4. The Urgent Threat of Clostridioides difficile Infection: A Glimpse of the Drugs of the Future, with Related Patents and Prospects;Biomedicines;2023-02-01

5. Inflammatory bowel disease and Clostridium difficile infection: clinical presentation, diagnosis, and management;Therapeutic Advances in Gastroenterology;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3